News

KTLA

Evommune Announces Late-Breaker Presentation of Phase 2 Data for EVO756 in Chronic Inducible Urticaria at Upcoming European Academy of Dermatology and Venereology (EADV) 2025 ...

PALO ALTO, Calif., Sept. 2, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory ...
KXAN

The First Presentation of TEECAD Product Registry Data at the American Society of Echocardiography 2025 Conference

The TEECAD data and system users support the technology for effective and safe probe placement as part of the new clinical workflow structure "If we look at society guidelines for TEE going back 25 ...
Northwestern University Clinical and Translational Sciences Institute

Collaborative Approach to Defining Data Sharing Metrics Named Finalist in NIH S-index Challenge

A collaborative multidisciplinary team that includes Northwestern’s Kristi Holmes, PhD has been named an NIH S-index ...
Business Wire

Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and ...
Morningstar

EDETEK Launches BioStat.AI: The Industry's First Unified AI Platform for Clinical Data, Biostatistics, and Programming

BioStat.AI is built on the foundation of EDETEK's flagship platforms, CONFORM™ and eClinical, and leverages advanced AI technologies including large language models (LLMs), machine learning, and ...
Investing

Marvell Q2 FY2026 presentation: data center revenue surges to 74% of total

Marvell’s presentation provides a strong indication that the company is successfully executing its AI-focused strategy. The dramatic growth in data center revenue suggests that Marvell is capitalizing ...